calcium acetate has been researched along with Calcinosis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (85.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floege, J | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Carvalho, AB; Cuppari, L; Dalboni, MA; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Muenz, LR; Qunibi, W | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Cuppari, L; Dalboni, MA; de Carvalho, AB; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Kim, TH; Yang, SY | 1 |
| Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Bommer, J; Chertow, GM; Raggi, P | 1 |
| Friedman, EA | 1 |
| Nolan, CR; Qunibi, WY | 1 |
| Qunibi, WY | 1 |
| Little, G; Otoo, A | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Acikel, C; Axelsson, J; Caglar, K; Cakir, E; Carrero, JJ; Eyileten, T; Lindholm, B; Oguz, Y; Saglam, M; Stenvinkel, P; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
| Dennis, VW; Fatica, RA | 1 |
5 review(s) available for calcium acetate and Calcinosis
| Article | Year |
|---|---|
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Topics: Acetates; Calcinosis; Calcium; Calcium Compounds; Cardiovascular Diseases; Diet; Humans; Hyperparathyroidism, Secondary; Phosphates; Renal Dialysis; Renal Insufficiency; Tomography, X-Ray Computed | 2005 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
7 trial(s) available for calcium acetate and Calcinosis
| Article | Year |
|---|---|
Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Topics: Acetates; Bone Remodeling; Brazil; Calcinosis; Calcium Compounds; Chelating Agents; Comorbidity; Coronary Artery Disease; Female; Humans; Incidence; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Topics: Acetates; Adult; alpha-2-HS-Glycoprotein; Blood Proteins; C-Reactive Protein; Calcinosis; Calcium; Calcium Compounds; Chelating Agents; Endothelium, Vascular; Homeostasis; Humans; Middle Aged; Phosphates; Polyamines; Prospective Studies; Renal Insufficiency, Chronic; Sevelamer; Treatment Outcome; Vascular Diseases; Vasodilation | 2008 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
8 other study(ies) available for calcium acetate and Calcinosis
| Article | Year |
|---|---|
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
Topics: Acetates; Adult; Bone Remodeling; Calcinosis; Calcium Compounds; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient.
Topics: Acetates; Biopsy; Calcinosis; Calcium Compounds; Chelating Agents; Fiber Optic Technology; Gastroscopy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stomach Diseases; Vitamin D; Vitamins | 2010 |
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Topics: Acetates; Blood Vessels; Calcinosis; Calcium Compounds; Chelating Agents; Disease Progression; Humans; Hyperphosphatemia; Lanthanum; Phosphate-Binding Proteins; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
The CARE study and cardiovascular calcification.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiomyopathies; Humans; United States | 2006 |
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Conflict, Psychological; Disease Management; Humans; Kidney Failure, Chronic; Phosphates; Treatment Outcome; United States | 2006 |
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |